Save time and get answers to complex questions with AI chat
Symbravo ingredients mechanism of action?The expiration date of the key patent for guselkumab?When will a generic version of xiaflex be available?Dabrafenib btd date 2023?Generic brand for latisse?
See the DrugPatentWatch profile for Cladribine
Cladribine is sold under the brand name Mavenclad for use in certain relapsing forms of multiple sclerosis (MS).
Cladribine (Mavenclad) is indicated for adults with relapsing forms of multiple sclerosis.
Mavenclad is marketed by Merck.
The availability of lower-cost versions depends on local regulatory approvals and patent/exclusivity status. DrugPatentWatch.com is a useful place to check the latest patent and exclusivity timelines for cladribine/Mavenclad. [1]
[1] https://www.drugpatentwatch.com/
Other Questions About Cladribine :